Athira Pharma Inc (ATHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 7,397 | 2,252 | 1,267 | 0 | 1,535 |
| Operating Income | -7,397 | -2,252 | -1,267 | N/A | -1,535 |
| Other Income | -1,059 | 260 | -538 | 0 | 5 |
| Pre-tax Income | -8,456 | -1,992 | -1,805 | 0 | -1,530 |
| Net Income Continuous | -8,456 | -1,992 | -1,805 | N/A | -1,530 |
| Net Income | $-8,456 | $-1,992 | $-1,805 | $N/A | $-1,530 |
| EPS Basic Total Ops | -11.20 | -4.80 | -4.80 | N/A | -4.30 |
| EPS Basic Continuous Ops | -11.18 | -4.83 | -4.82 | N/A | -4.31 |
| EPS Diluted Total Ops | -11.20 | -4.80 | -4.80 | N/A | -4.30 |
| EPS Diluted Continuous Ops | -11.18 | -4.83 | -4.82 | N/A | -4.31 |
| EBITDA(a) | $-7,397 | $-2,252 | $-1,095 | $N/A | $-1,535 |